Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.53 |
| ▸ | CES1 | P23141 | 4/20 | 0.51 |
| ▸ | ESR1 | P03372 | 3/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | TTR | P02766 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10431233 | 0.89 | FAAH (0.63) | FAAHCES1ESR1ESR2 | |
| SCHEMBL10431223 | 0.87 | FAAH (0.71) | FAAHCES1 | |
| SCHEMBL10431527 | 0.85 | ESR1 (0.46) | ESR1ESR2KDM4ECYP19A1ALDH1A1 | |
| SCHEMBL8258314 | 0.82 | FAAH (0.51) | FAAHCES1RECQL | |
| SCHEMBL1274684 | 0.82 | CES1 (0.73) | FAAHCES1ALDH1A1HDAC2HDAC8 | |
| SCHEMBL8980106 | 0.80 | CYP24A1 (0.51) | ESR1ESR2KDM4ECYP19A1ALDH1A1 | |
| SCHEMBL23512765 | 0.79 | FAAH (0.57) | FAAHCES1ALDH1A1CYP2C19HDAC2 | |
| SCHEMBL583919 | 0.79 | FFAR1 (0.65) | FAAHCES1HDAC2HDAC8LMNA | |
| SCHEMBL10388813 | 0.79 | FAAH (0.49) | FAAHCES1 | |
| SCHEMBL10431529 | 0.79 | CES1 (0.67) | CES1ESR1ESR2LMNACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12372525-B2 | Methods and kits for the diagnosis of influenza | BECTON, DICKINSON AND COMPANY (US) | 2025-07-29 | — | — | US | claimed |
| US-20220146514-A1 | METHODS AND KITS FOR THE DIAGNOSIS OF INFLUENZA | BECTON, DICKINSON AND COMPANY | 2022-05-12 | — | — | US | claimed |
| CN-108663518-B | Method and kit for influenza diagnosis | 贝克顿·迪金森公司 | 2022-03-11 | — | — | CN | claimed |
| US-11209433-B2 | Methods and kits for the diagnosis of influenza | BECTON, DICKINSON AND COMPANY (US) | 2021-12-28 | — | — | US | claimed |
| US-20190339272-A1 | METHODS AND KITS FOR THE DIAGNOSIS OF INFLUENZA | BECTON, DICKINSON AND COMPANY | 2019-11-07 | — | — | US | claimed |
| US-12372525-B2 | Methods and kits for the diagnosis of influenza | BECTON, DICKINSON AND COMPANY (US) | 2025-07-29 | — | — | US | disclosed |
| US-20240385182-A1 | MASKED FLUOROGENIC LIPID COMPOUNDS, LIPID PARTICLES COMPRISING THE SAME, AND METHODS OF USE THEREOF | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2024-11-21 | — | — | US | disclosed |
| US-20220146514-A1 | METHODS AND KITS FOR THE DIAGNOSIS OF INFLUENZA | BECTON, DICKINSON AND COMPANY | 2022-05-12 | — | — | US | disclosed |
| US-20220146514-A1 | METHODS AND KITS FOR THE DIAGNOSIS OF INFLUENZA | BECTON, DICKINSON AND COMPANY | 2022-05-12 | — | — | US | disclosed |
| CN-108663518-B | Method and kit for influenza diagnosis | 贝克顿·迪金森公司 | 2022-03-11 | — | — | CN | disclosed |
| US-11209433-B2 | Methods and kits for the diagnosis of influenza | BECTON, DICKINSON AND COMPANY (US) | 2021-12-28 | — | — | US | disclosed |
| US-11209433-B2 | Methods and kits for the diagnosis of influenza | BECTON, DICKINSON AND COMPANY (US) | 2021-12-28 | — | — | US | disclosed |
| US-5188937-A | Binding of signal antibody to antigen | BECTON, DICKINSON AND COMPANY (US) | 1993-02-23 | — | — | US | disclosed |
| EP-0501526-A2 | Fluoroketones as blocked enzyme inhibitors for use in immunoassays | Becton, Dickinson and Company (US) | 1992-09-02 | — | — | EP | disclosed |
| US-4962024-A | ADDING SECOND ENZYME AND BLOCKED FLUOROKETONE INHIBITOR OF THE SECOND ENZYME | BECTON, DICKINSON AND COMPANY (US) | 1990-10-09 | — | — | US | disclosed |
| EP-0369361-A2 | Immunoassay on a preblocked solid surface | Becton, Dickinson and Company (US) | 1990-05-23 | — | — | EP | disclosed |
| EP-0369657-A2 | Chromogenic substrate for esterase and immunoassay using same | Becton, Dickinson and Company (US) | 1990-05-23 | — | — | EP | disclosed |
| EP-0354548-A2 | Signal enhancement in assay for an enzyme | Becton, Dickinson and Company (US) | 1990-02-14 | — | — | EP | disclosed |
| US-4835099-A | Signal enhancement in immunoassay by modulation of enzymatic catalysis | BECTON, DICKINSON AND COMPANY (US) | 1989-05-30 | — | — | US | disclosed |
| EP-0271731-A2 | Signal enhancement in immunoassay by inhibition of enzymatic catalysis | Becton, Dickinson and Company (US) | 1988-06-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12372525-B2 | Methods and kits for the diagnosis of influenza | NEU3, NEU1, ADA | FAAH 1142/4885CES1 847/4885ESR1 3126/4885 |
| US-11209433-B2 | Methods and kits for the diagnosis of influenza | NEU3, NEU1, ADA | FAAH 1142/4885CES1 847/4885ESR1 3126/4885 |
| US-20240385182-A1 | MASKED FLUOROGENIC LIPID COMPOUNDS, LIPID PARTICLES COMPRISING THE SAME, AND METHODS OF USE THEREOF | GPX4, LIPA, ABHD16A | FAAH 467/4885CES1 382/4885ESR1 3588/4885 |
| US-20190339272-A1 | METHODS AND KITS FOR THE DIAGNOSIS OF INFLUENZA | NEU3, NEU1, ADA | FAAH 1142/4885CES1 847/4885ESR1 3126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.